Mark Krembil

Nova, Inc. offers a digital media distribution platform which provides content delivery on mobile devices. It develops HTML5-based solution to distribute media content in a multi-platform environment, including smart phones, tablets and desktops. The company was founded by Michael Russo, Kunal Gupta, Rahul Agarwal, Gaurav Jain and Pratik Rathod in 2007 and is headquartered in Toronto, Canada.

NoNO, Inc. operates as a biotherapeutics company. It engages in the research, development, and commercialization of pharmaceuticals for the treatment of common health disorders that include strokes, traumatic brain injuries, and pains. The company was founded by Michael Tymianski and Michael W. Salter in 2003 and is headquartered in Toronto, Canada.

Arthritis Innovation Corp. operates as a clinical-stage pharmaceutical company addressing unmet needs in Orthopedic surgery and Arthritis management. Its first drug in Phase 2 clinical testing uses sustained local delivery of an NSAID after total knee replacement to manage pain and inflammation as an alternative to oral NSAIDs or narcotics. The company was founded in 2013 and is headquartered in Toronto, Canada.

Part of Pluristyx, Inc., panCELLa, Inc. is a privately held early-stage biotechnology firm based in Toronto, CA. panCELLa was acquired by Pluristyx, Inc. on October 06, 2022. panCELLa has secured partnerships with several biotechnology partners to enhance its patent position and provide expanded access to its exclusive failsafe™ and cloaked cells™/iact cells. The Canadian company continues its internal R & D efforts to develop additional novel uses of its platform technologies in areas such as bio-production, cancer vaccination, and tolerization. The company was founded in 2015 by Armand Keating and Andras Nagy, and has created platforms that allow for the development of safe, universal, cost-effective, “ off-the-shelf ” therapeutic cell products for medicine.